Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1994 2
1995 4
1996 2
1997 2
1998 2
1999 2
2000 7
2001 4
2002 1
2003 1
2004 1
2005 2
2006 2
2007 2
2008 6
2009 12
2010 7
2011 11
2012 15
2013 18
2014 20
2015 20
2016 17
2017 13
2018 11
2019 21
2020 17
2021 21
2022 19
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

234 results
Results by year
Filters applied: . Clear all
Page 1
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Henricks LM, Lunenburg CATC, de Man FM, Meulendijks D, Frederix GWJ, Kienhuis E, Creemers GJ, Baars A, Dezentjé VO, Imholz ALT, Jeurissen FJF, Portielje JEA, Jansen RLH, Hamberg P, Ten Tije AJ, Droogendijk HJ, Koopman M, Nieboer P, van de Poel MHW, Mandigers CMPW, Rosing H, Beijnen JH, Werkhoven EV, van Kuilenburg ABP, van Schaik RHN, Mathijssen RHJ, Swen JJ, Gelderblom H, Cats A, Guchelaar HJ, Schellens JHM. Henricks LM, et al. Among authors: de man fm. Lancet Oncol. 2018 Nov;19(11):1459-1467. doi: 10.1016/S1470-2045(18)30686-7. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348537
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients.
Hulshof EC, de With M, de Man FM, Creemers GJ, Deiman BALM, Swen JJ, Houterman S, Koolen SLW, Bins S, Thijs AMJ, Laven MMJ, Hövels AM, Luelmo SAC, Houtsma D, Shulman K, McLeod HL, van Schaik RHN, Guchelaar HJ, Mathijssen RHJ, Gelderblom H, Deenen MJ. Hulshof EC, et al. Among authors: de man fm. Eur J Cancer. 2022 Feb;162:148-157. doi: 10.1016/j.ejca.2021.12.009. Epub 2022 Jan 5. Eur J Cancer. 2022. PMID: 34998046 Free article.
Neurohormonal modulation in pulmonary arterial hypertension.
Peters EL, Bogaard HJ, Vonk Noordegraaf A, de Man FS. Peters EL, et al. Among authors: de man fs. Eur Respir J. 2021 Oct 28;58(4):2004633. doi: 10.1183/13993003.04633-2020. Print 2021 Oct. Eur Respir J. 2021. PMID: 33766951 Free PMC article. Review.
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
Aman J, Duijvelaar E, Botros L, Kianzad A, Schippers JR, Smeele PJ, Azhang S, Bartelink IH, Bayoumy AA, Bet PM, Boersma W, Bonta PI, Boomars KAT, Bos LDJ, van Bragt JJMH, Braunstahl GJ, Celant LR, Eger KAB, Geelhoed JJM, van Glabbeek YLE, Grotjohan HP, Hagens LA, Happe CM, Hazes BD, Heunks LMA, van den Heuvel M, Hoefsloot W, Hoek RJA, Hoekstra R, Hofstee HMA, Juffermans NP, Kemper EM, Kos R, Kunst PWA, Lammers A, van der Lee I, van der Lee EL, Maitland-van der Zee AH, Mau Asam PFM, Mieras A, Muller M, Neefjes ECW, Nossent EJ, Oswald LMA, Overbeek MJ, Pamplona CC, Paternotte N, Pronk N, de Raaf MA, van Raaij BFM, Reijrink M, Schultz MJ, Serpa Neto A, Slob EMA, Smeenk FWJM, Smit MR, Smits AJ, Stalenhoef JE, Tuinman PR, Vanhove ALEM, Wessels JN, van Wezenbeek JCC, Vonk Noordegraaf A, de Man FS, Bogaard HJ. Aman J, et al. Among authors: de man fs. Lancet Respir Med. 2021 Sep;9(9):957-968. doi: 10.1016/S2213-2600(21)00237-X. Epub 2021 Jun 18. Lancet Respir Med. 2021. PMID: 34147142 Free PMC article. Clinical Trial.
Pressure-overload-induced right heart failure.
Rain S, Handoko ML, Vonk Noordegraaf A, Bogaard HJ, van der Velden J, de Man FS. Rain S, et al. Among authors: de man fs. Pflugers Arch. 2014 Jun;466(6):1055-63. doi: 10.1007/s00424-014-1450-1. Epub 2014 Feb 1. Pflugers Arch. 2014. PMID: 24488007 Review.
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension.
Manz XD, Szulcek R, Pan X, Symersky P, Dickhoff C, Majolée J, Kremer V, Michielon E, Jordanova ES, Radonic T, Bijnsdorp IV, Piersma SR, Pham TV, Jimenez CR, Vonk Noordegraaf A, de Man FS, Boon RA, Voorberg J, Hordijk PL, Aman J, Bogaard HJ. Manz XD, et al. Among authors: de man fs. Am J Respir Crit Care Med. 2022 Apr 1;205(7):806-818. doi: 10.1164/rccm.202109-2075OC. Am J Respir Crit Care Med. 2022. PMID: 35081007
Use of β-Blockers in Pulmonary Hypertension.
Perros F, de Man FS, Bogaard HJ, Antigny F, Simonneau G, Bonnet S, Provencher S, Galiè N, Humbert M. Perros F, et al. Among authors: de man fs. Circ Heart Fail. 2017 Apr;10(4):e003703. doi: 10.1161/CIRCHEARTFAILURE.116.003703. Circ Heart Fail. 2017. PMID: 28364092 Review.
Right Ventricular Fibrosis.
Andersen S, Nielsen-Kudsk JE, Vonk Noordegraaf A, de Man FS. Andersen S, et al. Among authors: de man fs. Circulation. 2019 Jan 8;139(2):269-285. doi: 10.1161/CIRCULATIONAHA.118.035326. Circulation. 2019. PMID: 30615500
The right treatment for the right ventricle.
Groeneveldt JA, de Man FS, Westerhof BE. Groeneveldt JA, et al. Among authors: de man fs. Curr Opin Pulm Med. 2019 Sep;25(5):410-417. doi: 10.1097/MCP.0000000000000610. Curr Opin Pulm Med. 2019. PMID: 31365374 Free PMC article. Review.
234 results